BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19915667)

  • 1. Genetic association analysis of the functional c.714T>G polymorphism and mucosal expression of dectin-1 in inflammatory bowel disease.
    de Vries HS; Plantinga TS; van Krieken JH; Stienstra R; van Bodegraven AA; Festen EA; Weersma RK; Crusius JB; Linskens RK; Joosten LA; Netea MG; de Jong DJ
    PLoS One; 2009 Nov; 4(11):e7818. PubMed ID: 19915667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Y238X stop codon polymorphism in the human β-glucan receptor dectin-1 and susceptibility to invasive aspergillosis.
    Chai LY; de Boer MG; van der Velden WJ; Plantinga TS; van Spriel AB; Jacobs C; Halkes CJ; Vonk AG; Blijlevens NM; van Dissel JT; Donnelly PJ; Kullberg BJ; Maertens J; Netea MG
    J Infect Dis; 2011 Mar; 203(5):736-43. PubMed ID: 21242599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional consequences of DECTIN-1 early stop codon polymorphism Y238X in rheumatoid arthritis.
    Plantinga TS; Fransen J; Takahashi N; Stienstra R; van Riel PL; van den Berg WB; Netea MG; Joosten LA
    Arthritis Res Ther; 2010; 12(1):R26. PubMed ID: 20158887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variation in the dectin-1/CARD9 recognition pathway and susceptibility to candidemia.
    Rosentul DC; Plantinga TS; Oosting M; Scott WK; Velez Edwards DR; Smith PB; Alexander BD; Yang JC; Laird GM; Joosten LA; van der Meer JW; Perfect JR; Kullberg BJ; Netea MG; Johnson MD
    J Infect Dis; 2011 Oct; 204(7):1138-45. PubMed ID: 21881131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the selenoprotein S (SELS) gene -105G>A promoter polymorphism in inflammatory bowel disease and regulation of SELS gene expression in intestinal inflammation.
    Seiderer J; Dambacher J; Kühnlein B; Pfennig S; Konrad A; Török HP; Haller D; Göke B; Ochsenkühn T; Lohse P; Brand S
    Tissue Antigens; 2007 Sep; 70(3):238-46. PubMed ID: 17661913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD.
    Seiderer J; Elben I; Diegelmann J; Glas J; Stallhofer J; Tillack C; Pfennig S; Jürgens M; Schmechel S; Konrad A; Göke B; Ochsenkühn T; Müller-Myhsok B; Lohse P; Brand S
    Inflamm Bowel Dis; 2008 Apr; 14(4):437-45. PubMed ID: 18088064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic variants in TNF-alpha but not DLG5 are associated with inflammatory bowel disease in a large United Kingdom cohort.
    Tremelling M; Waller S; Bredin F; Greenfield S; Parkes M
    Inflamm Bowel Dis; 2006 Mar; 12(3):178-84. PubMed ID: 16534418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divergent Roles for Macrophage C-type Lectin Receptors, Dectin-1 and Mannose Receptors, in the Intestinal Inflammatory Response.
    Rahabi M; Jacquemin G; Prat M; Meunier E; AlaEddine M; Bertrand B; Lefèvre L; Benmoussa K; Batigne P; Aubouy A; Auwerx J; Kirzin S; Bonnet D; Danjoux M; Pipy B; Alric L; Authier H; Coste A
    Cell Rep; 2020 Mar; 30(13):4386-4398.e5. PubMed ID: 32234475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific association of a CLEC16A/KIAA0350 polymorphism with NOD2/CARD15(-) Crohn's disease patients.
    Márquez A; Varadé J; Robledo G; Martínez A; Mendoza JL; Taxonera C; Fernández-Arquero M; Díaz-Rubio M; Gómez-García M; López-Nevot MA; de la Concha EG; Martín J; Urcelay E
    Eur J Hum Genet; 2009 Oct; 17(10):1304-8. PubMed ID: 19337309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity.
    Cunha C; Di Ianni M; Bozza S; Giovannini G; Zagarella S; Zelante T; D'Angelo C; Pierini A; Pitzurra L; Falzetti F; Carotti A; Perruccio K; Latgé JP; Rodrigues F; Velardi A; Aversa F; Romani L; Carvalho A
    Blood; 2010 Dec; 116(24):5394-402. PubMed ID: 20807886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTLA4 CT60 single-nucleotide polymorphism is associated with Slovenian inflammatory bowel disease patients and regulates expression of CTLA4 isoforms.
    Repnik K; Potocnik U
    DNA Cell Biol; 2010 Oct; 29(10):603-10. PubMed ID: 20491567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insoluble beta-glucan from the cell wall of Candida albicans induces immune responses of human THP-1 monocytes through Dectin-1.
    Li M; Liu ZH; Chen Q; Zhou WQ; Yu MW; Lü GX; Lü XL; Shen YN; Liu WD; Wu SX
    Chin Med J (Engl); 2009 Mar; 122(5):496-501. PubMed ID: 19323897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colonic expression of the peptide transporter PEPT1 is downregulated during intestinal inflammation and is not required for NOD2-dependent immune activation.
    Wuensch T; Ullrich S; Schulz S; Chamaillard M; Schaltenberg N; Rath E; Goebel U; Sartor RB; Prager M; Büning C; Bugert P; Witt H; Haller D; Daniel H
    Inflamm Bowel Dis; 2014 Apr; 20(4):671-84. PubMed ID: 24583477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients.
    Plantinga TS; van der Velden WJ; Ferwerda B; van Spriel AB; Adema G; Feuth T; Donnelly JP; Brown GD; Kullberg BJ; Blijlevens NM; Netea MG
    Clin Infect Dis; 2009 Sep; 49(5):724-32. PubMed ID: 19614557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1 receptor antagonist VNTR-polymorphism in inflammatory bowel disease.
    Vijgen L; Van Gysel M; Rector A; Thoelen I; Esters N; Ceelen T; Vangoidsenhoven E; Vermeire S; Rutgeerts P; Van Ranst M
    Genes Immun; 2002 Nov; 3(7):400-6. PubMed ID: 12424621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
    Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTLA-4 (+49A/G) and NOD2/CARD15 (N852S) polymorphisms with inflammatory bowel disease in Turkish patients.
    Budak Diler S; Yaraş S
    Cell Mol Biol (Noisy-le-grand); 2018 Aug; 64(11):97-101. PubMed ID: 30213296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic determinants associated with early age of diagnosis of IBD.
    Connelly TM; Berg AS; Harris L; Brinton D; Deiling S; Koltun WA
    Dis Colon Rectum; 2015 Mar; 58(3):321-7. PubMed ID: 25664710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.
    Cantor MJ; Nickerson P; Bernstein CN
    Am J Gastroenterol; 2005 May; 100(5):1134-42. PubMed ID: 15842590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.